North America Cancer Screening Market (2018-2023)

Publisher Name :
Date: 19-Sep-2018
No. of pages: 90

North America cancer screening market

North America is leading the cancer screening market. The region is technologically equipped and being a developed economy it is efficiently catering t- the rising incidence of cancer cases. The market is forecasted t- grow at a compound annual growth rate (CAGR) f 11.14% resulting in an annual revenue of USD 16.36 Bn during the forecast period 2018-2023.

Companies are focusing on research & development (R&D) and entering int- collaborations with the government t- expand regional access.

By end users, the market is segmented int- hospitals, laboratories and independent physicians and clinics. The Laboratory segment will witness a progressive growth during the forecast period 2018-2023 while the hospital segment will account for the maximum revenue of USD 11.18 billion during the forecast period.

By screening type, the market is segmented int- laboratory, genetic, imaging, biopsy and endoscopy tests. Genetic and biopsy will be the leading segments during the forecast period 2018-2023.

By application type, the market can be segmented int- lung, breast, melanoma, kidney and colorectal cancer types. Colorectal, kidney, melanoma and breast cancer will occupy a larger share of the market during the forecast period 2018-2023.

By countries, the market is divided int- the United States Of America (U.S.A.) , Canada and others (the rest of North America).

Key growth factors

The rising incidence of cancer cases has led t- a growing need among people t- seek early cure and diagnosis. Technological advancements being adopted at a rapid pace t- combat the rapid spread of cancer are the key growth factors for the market.

Threats and key players

The North America cancer screening market is a mature market for cancer screening and is forecasted t- grow at a growth rate of 8.3%. But regulatory hindrances in the form of policies and norms which has the potential t- impact the growth of the market.

Key players in the North America cancer screening market are GE Healthcare, Siemens Healthcare GmbH, Hologic Inc., Therm- Fisher Scientific, etc.

What is covered in the report?

1. Overview of the North America cancer screening market.

2. Market drivers and challenges in the North America cancer screening market.

3. Market trends in the North America cancer screening market.

4. Historical, current and forecasted market size data for the North America market segmentation based on type of end user (hospitals, laboratories , independent physicians and clinics) - by type of screening (laboratory, genetic, imaging, biopsy and endoscopy) -by type of application (lung, breast, melanoma, kidney and colorectal)

5. Historical, current and forecasted market size data for the North America market segmentation based on type of end-user (hospitals, laboratories, independent physicians and clinics) - by type of screening (laboratory, genetic, imaging, biopsy and endoscopy) -by type of application (lung, breast, melanoma, kidney and colorectal).

6. Historical, current and forecasted market size data of cancer screening market by countries U.S.A., Canada and others (the rest of North America) - by revenue.

7. Historical, current and forecasted market size data for country-wise segments - by revenue.

8. Analysis of the competitive landscape and profiles of major competitors operating in the North American market.

Why buy?

- Understand the demand for cancer screening market t- determine the viability of the market.

- Understand the country-specific market size and observations for each segment.

- Develop strategies based on the drivers, trends and highlights for each of the segments.

- Evaluate the value chain t- determine the workflow and t- get an idea of the current position where you are placed.

- Recognize the key competitors of this market and respond accordingly.

- Identify the initiatives and growth strategies taken by the major companies and decide the direction of further growth.

- Define the competitive positioning by comparing the products and services compared with the key players in the market.

Customizations available

With the given market data, Netscribes offers customizations according t- specific needs. Write t- us at [email protected]

North America Cancer Screening Market (2018-2023)

Table of Contents

Chapter 1: Executive summary
1.1 Market scope and segmentation
1.2 Key questions answered in this study
1.3 Executive summary

Chapter 2: North America cancer screening market - market overview
2.1. North America market overview - market trends, market attractiveness analysis, country-wise market revenue (USD)
2.2. North America - market drivers and challenges
2.3. Value chain analysis - cancer screening market
2.4. Porter's five forces analysis
2.5. Market segmentation based on type of end users (hospitals, laboratories, independent physicians and clinics)
2.5. a. Hospitals - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. b. Laboratory - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. c. Independent physicians and clinics revenue - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. d. Growth drivers and key challenges
2.6. Market segmentation based on type of screening (laboratory, genetic, imaging, biopsy and endoscopy) Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn).
2.6. a. Laboratory - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. b. Genetic - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. c. Imaging - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. d. Biopsy - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. e. Endoscopy - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. f. Growth drivers and key challenges
2.7. Market segmentation based on type of application (lung, breast, melanoma, kidney and colorectal) Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn).
2.7. a. Lung - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7. b. Breast - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7. c. Melanoma - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7. d. Kidney - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7. e. Colorectal - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7. f. Growth drivers and key challenges
2.8. Major country penetration

Chapter 3. The USA cancer screening market
3.1. The USA market overview - market trends, market attractiveness analysis, country-wise market revenue (USD)
3.2. Market segmentation based on type of end users (hospitals, laboratories, independent physicians and clinics)
3.2. a. Hospitals - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2. b. Laboratory - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2. c. Independent physicians and clinics revenue - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2. d. Growth drivers and key challenges
3.3. Market segmentation based on type of screening (laboratory, genetic, imaging, biopsy and endoscopy) Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn).
3.3. a. Laboratory - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3. b. Genetic - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3. c. Imaging - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3. d. Biopsy - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3. e. Endoscopy - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3. f. Growth drivers and key challenges
3.4. Market segmentation based on type of application (lung, breast, melanoma, kidney and colorectal) Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn).
3.4. a. Lung - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.4. b. Breast - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.4. c. Melanoma - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.4. d. Kidney - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.4. e. Colorectal - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.4. f. Growth drivers and key challenges

Chapter 4. Canada smart manufacturing industry 4.0 market
4.1. Canada market overview - market trends, market attractiveness analysis, country-wise market revenue (USD)
4.2. Market segmentation based on type of end users (hospitals, laboratories, independent physicians and clinics)
4.2. a. Hospitals - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.2. b. Laboratory - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.2. c. Independent physicians and clinics revenue - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.2. d. Growth drivers and key challenges
4.3. Market segmentation based on type of screening (laboratory, genetic, imaging, biopsy and endoscopy) Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn).
4.3. a. Laboratory - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.3. b. Genetic - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.3. c. Imaging - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.3. d. Biopsy - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.3. e. Endoscopy - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.3. f. Growth drivers and key challenges
4.4. Market segmentation based on type of application (lung, breast, melanoma, kidney and colorectal) Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn).
4.4. a. Lung - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.4. b. Breast - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.4. c. Melanoma - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.4. d. Kidney - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.4. e. Colorectal - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.4. f. Growth drivers and key challenges

Chapter 5. Others (the rest of North America) smart manufacturing industry 4.0 market
5.1. Others (the rest of North America) market overview - market trends, market attractiveness analysis, country-wise market revenue (USD)
5.2. Market segmentation based on type of end users (hospitals, laboratory, independent physicians and clinics)
5.2. a. Hospitals - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.2. b. Laboratory - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.2. c. Independent physicians and clinics revenue - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.2. d. Growth drivers and key challenges
5.3. Market segmentation based on type of screening (laboratory, genetic, imaging, biopsy and endoscopy) Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn).
5.3. a. Laboratory - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.3. b. Genetic - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.3. c. Imaging - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.3. d. Biopsy - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.3. e. Endoscopy - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.3. f. Growth drivers and key challenges
5.4. Market segmentation based on type of application (lung, breast, melanoma, kidney and colorectal) Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn).
5.4. a. Lung - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.4. b. Breast - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.4. c. Melanoma - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.4. d. Kidney - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.4. e. Colorectal - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.4. f. Growth drivers and key challenges

Chapter 6: Competitive landscape
6.1. GE Healthcare
6.1. a. Company snapshot
6.1. b. Product offerings
6.1. c. Growth strategies
6.1. d. Initiatives
6.1. e. Geographical presence
6.1. f. Key numbers
6.2. Siemens Healthineers
6.2. a. Company snapshot
6.2. b. Product offerings
6.2. c. Growth strategies
6.2. d. Initiatives
6.2. e. Geographical presence
6.2. f. Key numbers
6.3. Hologic Inc.
6.3. a. Company snapshot
6.3. b. Product offerings
6.3. c. Growth strategies
6.3. d. Initiatives
6.3. e. Geographical presence
6.3. f. Key numbers
6.4. Thermo Fisher Scientific
6.4. a. Company snapshot
6.4. b. Product offerings
6.4. c. Growth strategies
6.4. d. Initiatives
6.4. e. Geographical presence
6.4. f. Key numbers
6.5. Roche Diagnostics
6.5. a. Company snapshot
6.5. b. Product offerings
6.5. c. Growth strategies
6.5. d. Initiatives
6.5. e. Geographical presence
6.5. f. Key numbers

Chapter 7: Conclusion

Chapter 8: Appendix
8.1. List of tables
8.2. Assumptions
8.3. Research and methodology
8.4. About Netscribes Inc.
Note: The Table of Contents (Toc) provided above contains the targeted coverage. The coverage is subject to change as we progress with the research.
Disclaimer: The report will be delivered within 5-7 business days post payment confirmation
  • 2020 Global Cancer Diagnostics Market Players--Market Shares by Country, Strategic Assessments of Major Suppliers and Emerging Market Entrants
    Published: 24-Feb-2020        Price: US 4500 Onwards        Pages: 80
    This new report from LeadingMarketResearch.com provides strategic assessments of major cancer diagnostic product suppliers and emerging market entrants. The report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.Contains 80 pages......
  • 2020 Cancer Diagnostics Market Segmentation Analysis: US, Europe, Japan--Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
    Published: 21-Feb-2020        Price: US 27500 Onwards        Pages: 1200
    The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. This new report from LeadingMarketResearch.com is based on a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U.S., Europe and Asia; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts......
  • 2020 Europe Cancer Diagnostics Market Segmentation Analysis: France, Germany, Italy, Spain, UK--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
    Published: 21-Feb-2020        Price: US 17500 Onwards        Pages: 820
    The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. This new report from LeadingMarketResearch.com is based on a study of the major business opportunities emerging in the European cancer diagnostics market during the next five years. The report examines trends in the European market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sal......
  • 2020 France Cancer Diagnostics Market Segmentation Analysis: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
    Published: 21-Feb-2020        Price: US 4750 Onwards        Pages: 585
    The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. This new report from LeadingMarketResearch.com is based on a study of the major business opportunities emerging in the French cancer diagnostics market during the next five years. The report examines trends in the French market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major t......
  • 2020 Germany Cancer Diagnostics Market Segmentation Analysis: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
    Published: 21-Feb-2020        Price: US 4750 Onwards        Pages: 585
    The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. This new report from LeadingMarketResearch.com is based on a study of the major business opportunities emerging in the German cancer diagnostics market during the next five years. The report examines trends in the German market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major t......
  • 2020 Italy Cancer Diagnostics Market Segmentation Analysis: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
    Published: 21-Feb-2020        Price: US 4750 Onwards        Pages: 570
    The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. This new report from LeadingMarketResearch.com is based on a study of the major business opportunities emerging in the Italian cancer diagnostics market during the next five years. The report examines trends in the Italian market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major......
  • 2020 Japan Cancer Diagnostics Market Segmentation Analysis: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
    Published: 21-Feb-2020        Price: US 4750 Onwards        Pages: 590
    The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. This new report from LeadingMarketResearch.com is based on a study of the major business opportunities emerging in the Japanese cancer diagnostics market during the next five years. The report examines trends in the Japanese market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of maj......
  • 2020 Spain Cancer Diagnostics Market Segmentation Analysis: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
    Published: 21-Feb-2020        Price: US 4750 Onwards        Pages: 565
    The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. LeadingMarketResearch.com's new report is based on a study of the major business opportunities emerging in the Spanish cancer diagnostics market during the next five years. The report examines trends in the Spanish market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor ......
  • 2020 UK Cancer Diagnostics Market Segmentation Analysis: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
    Published: 21-Feb-2020        Price: US 4750 Onwards        Pages: 565
    The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. This new report from LeadingMarketResearch.com is based on a study of the major business opportunities emerging in the UK cancer diagnostics market during the next five years. The report examines trends in the UK market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor mar......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs